- ISIN
- US98945L1052
- CUSIP
- 98945L105
- Sector
- Technology
- IPO Date
- Feb 8, 2018
Highlights
- Market Cap
- $4.80M
- Enterprise Value
- $304.09M
- EPS (TTM)
- -CN¥33.26
- Total Revenue (TTM)
- CN¥1.92B
- Gross Profit (TTM)
- CN¥743.06M
- EBITDA (TTM)
- -CN¥179.07M
- Year Range
- $2.44 - $61.85
- Target Price
- $12.00
- ROA (TTM)
- -7.63%
- ROE (TTM)
- -20.94%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ZEPP Performance Chart
Zepp Health Corporation (ZEPP) is down 82.0% since the beginning of the year. At $5 per share, ZEPP is trading 92.2% below its 52-week high of $62. Investors who bought $1,000 worth of ZEPP shares 5 years ago would now be looking at an investment worth $113.
Loading charts...
Returns By Period
Zepp Health Corporation (ZEPP) has returned -82.03% so far this year and 99.18% over the past 12 months.
Zepp Health Corporation
- 1D
- 0.21%
- 1M
- -43.85%
- YTD
- -82.03%
- 6M
- -83.31%
- 1Y
- 99.18%
- 3Y*
- 2.61%
- 5Y*
- -35.33%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ZEPP Monthly Returns History
Based on dividend-adjusted daily data since Feb 8, 2018, ZEPP's average daily return is +0.03%, while the average monthly return is +3.45%. At this rate, an investment would double in approximately 1.7 years.
Historically, 38% of months were positive and 62% were negative. The best month was Jul 2025 with a return of +406.0%, while the worst month was May 2026 at -53.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.
On a daily basis, ZEPP closed higher 45% of trading days. The best single day was Jul 11, 2025 with a return of +69.5%, while the worst single day was Jun 9, 2026 at -28.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -33.11% | 6.99% | -38.02% | 46.19% | -53.29% | -40.69% | -82.03% | ||||||
| 2025 | 7.69% | -4.64% | 10.86% | -12.16% | -2.50% | 4.93% | 406.02% | 234.32% | 1.73% | -11.80% | -33.26% | -0.04% | 936.15% |
| 2024 | -14.08% | -7.38% | -9.73% | -17.65% | -9.38% | -21.18% | -4.80% | 31.30% | 45.00% | -26.21% | -2.18% | -17.20% | -54.23% |
| 2023 | 42.76% | -18.36% | -22.49% | 11.45% | -19.18% | -3.39% | 14.04% | -16.92% | 6.48% | -10.43% | 33.98% | 2.90% | -2.07% |
| 2022 | -1.39% | -26.91% | -18.20% | -15.97% | -15.70% | -9.31% | -5.95% | 9.77% | -28.27% | -10.22% | -2.44% | 20.83% | -70.31% |
| 2021 | 15.70% | 20.57% | -34.85% | -4.64% | -2.73% | 17.52% | -5.11% | -2.33% | -26.19% | 2.24% | -17.30% | -25.63% | -57.38% |
Benchmark Metrics
Zepp Health Corporation has an annualized alpha of -6.55%, beta of 0.97, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since February 08, 2018.
- This stock participated in 184.59% of S&P 500 Index downside but only 58.91% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -6.55%
- Beta
- 0.97
- R²
- 0.05
- Upside Capture
- 58.91%
- Downside Capture
- 184.59%
Return for Risk
Risk / Return Rank
ZEPP ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zepp Health Corporation (ZEPP) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZEPP | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.42 | ||
| Sortino ratioReturn per unit of downside risk | -0.53 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.37 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.07 | 2.78 | -1.72 |
| Martin ratioReturn relative to average drawdown | 1.78 | 12.44 | -10.66 |
Dividends
Dividend History
Zepp Health Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 6.90% |
Monthly Dividends
The table displays the monthly dividend distributions for Zepp Health Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.40 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.40 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zepp Health Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zepp Health Corporation was 97.30%, occurring on Aug 5, 2024. The portfolio has not yet recovered.
The current Zepp Health Corporation drawdown is 93.66%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -97.30%Aug 2024 | 3y 5mo | — | 5y 4moFeb 2021 - now |
2019 bear market2019 | -61.54%May 2019 | 2mo 28d | 1y 8mo | 1y 11moMar 2019 - Feb 2021 |
2018 bear market2018 | -35.78%Jun 2018 | 15d | 7mo 23d | 8mo 8dJun 2018 - Feb 2019 |
2018 bear market2018 | -27.42%Apr 2018 | 2mo 15d | 1mo 18d | 4mo 3dFeb 2018 - Jun 2018 |
2019 pullback2019 | -1.49%Feb 2019 | 0s | 2d | 2dFeb 2019 - Mar 2019 |
Drawdown Indicators
| ZEPP | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.30% | -56.78% | -40.52% |
Max Drawdown (1Y)Largest decline over 1 year | -93.49% | -9.10% | -84.39% |
Max Drawdown (3Y)Largest decline over 3 years | -93.49% | -18.90% | -74.59% |
Max Drawdown (5Y)Largest decline over 5 years | -95.72% | -25.43% | -70.29% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -93.66% | -1.80% | -91.86% |
Average DrawdownAverage peak-to-trough decline | -62.83% | -10.71% | -52.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 55.96% | 2.03% | +53.93% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zepp Health Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zepp Health Corporation is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZEPP relative to other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZEPP in comparison with other companies in the Scientific & Technical Instruments industry. Currently, ZEPP has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ZEPP
Add Zepp Health Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ZEPP